Photodynamic therapy: a light in the darkness?
Photodynamic therapy (PDT) is used to treat localized premalignant or early malignant disease. This study reports the enhanced, systemic antitumor immune response from PDT, suggesting that it may have a potential role as a therapy to address both local and disseminated disease.
Lin
Alexander
A
University of Pennsylvania, Department of Radiation Oncology, Philadelphia, Pennsylvania, USA. lina@xrt.upenn.edu
Hahn
Stephen M
SM
D000818:Animals; D019496:Cancer Vaccines / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004353:Drug Evaluation, Preclinical; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D008954:Models, Biological; D010778:Photochemotherapy / Q000639:trends*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000628:therapy; D016896:Treatment Outcome
D019496:Cancer Vaccines